Pfizer · NSE: PFIZER · BSE: 500680
Q2 FY21 results · Jul–Sep 2020
Pfizer reported revenue from operations of ₹595.41 crore (up 5.0% from Q2 FY20) and net profit of ₹131.37 crore (down 14.8% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 595.41 | 567.06 | +5.0% | 514.89 | +15.6% |
| Other income | 12.15 | 44.75 | −72.8% | 17.20 | −29.4% |
| Total income | 607.56 | 611.81 | −0.7% | 532.09 | +14.2% |
| Profit before tax | 183.03 | 181.18 | +1.0% | 173.34 | +5.6% |
| Net profit for the period | 131.37 | 154.25 | −14.8% | 124.45 | +5.6% |
| EPS, basic (₹) | 28.71 | 33.72 | −14.9% | 27.20 | +5.6% |
| Net margin (%) | 22.1 | 27.2 | 24.2 |
Standalone
- Filed with BSE
- 02 Nov 2020, 18:03 IST
- Board meeting
- 02 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE